Protocol for a scoping review exploring the use of patient reported outcomes in adult social care by Hughes, Sarah E. et al.
1Hughes SE, et al. BMJ Open 2021;11:e045206. doi:10.1136/bmjopen-2020-045206
Open access 
Protocol for a scoping review exploring 
the use of patient- reported outcomes in 
adult social care
Sarah E Hughes   ,1,2,3 Olalekan Lee Aiyegbusi,1,2,3,4,5 Daniel S Lasserson,6 
Philip Collis,1 Samantha Cruz Rivera   ,1,2,7 Christel McMullan   ,1,2 
Grace M Turner,1,2 Jon Glasby,8 Melanie Calvert   1,2,3,4,7,9
To cite: Hughes SE, 
Aiyegbusi OL, Lasserson DS, 
et al.  Protocol for a scoping 
review exploring the use of 
patient- reported outcomes in 
adult social care. BMJ Open 
2021;11:e045206. doi:10.1136/
bmjopen-2020-045206
 ► Prepublication history and 
additional supplemental material 
for this paper are available 
online. To view these files, 
please visit the journal online 
(http:// dx. doi. org/ 10. 1136/ 
bmjopen- 2020- 045206).
Received 24 September 2020
Revised 02 February 2021
Accepted 12 March 2021
For numbered affiliations see 
end of article.
Correspondence to
Sarah E Hughes;  
 s. e. hughes@ bham. ac. uk
Protocol
© Author(s) (or their 
employer(s)) 2021. Re- use 
permitted under CC BY. 
Published by BMJ.
ABSTRACT
Introduction Patient- reported outcomes (PROs) are 
measures of a person’s own views of their health, 
functioning and quality of life. They are typically assessed 
using validated, self- completed questionnaires known 
as patient- reported outcome measures (PROMs). 
PROMs are used in healthcare settings to support care 
planning, clinical decision- making, patient–practitioner 
communication and quality improvement. PROMs have 
a potential role in the delivery of social care where 
people often have multiple and complex long- term health 
conditions. However, the use of PROMs in this context is 
currently unclear. The objective of this scoping review is to 
explore the evidence relating to the use of PROMs in adult 
social care.
Methods and analyses The electronic databases Medline 
(Ovid), PsychInfo (Ovid), ASSIA (ProQuest), Social Care 
Online (SCIE), Web of Science and EMBASE (Ovid) were 
searched on 29 September 2020 to identify eligible studies 
and other publically available documents published since 
2010. A grey literature search and hand searching of 
citations and reference lists of the included studies will 
also be undertaken. No restrictions on study design or 
language of publication will be applied. Screening and 
data extraction will be completed independently by two 
reviewers. Quality appraisal of the included documents 
will use the Critical Appraisal Skills Programme and 
AACODS (Authority, Accuracy, Coverage, Objectivity, Date, 
Significance) checklists. A customised data charting table 
will be used for data extraction, with analysis of qualitative 
data using the framework method. The review findings will 
be presented as tables and in a narrative summary.
Ethics and dissemination Ethical review is not required 
as scoping reviews are a form of secondary data analysis 
that synthesise data from publically available sources. 
Review findings will be shared with service users and 
other relevant stakeholders and disseminated through a 
peer- reviewed publication and conference presentations. 
This protocol is registered on the Open Science Framework 
( www. osf. io).
INTRODUCTION
People with care and support needs often live 
with multiple and complex, long- term health 
conditions.1 They are likely to experience 
greater levels of disability and have complex 
care and support needs.2 3 An understanding 
of a person’s own views about their health 
can help ensure care and support is provided 
in a way that is holistic, person- centred and 
responsive. Such insights are particularly rele-
vant in the UK where a fragmented health 
and social care system make the coordination 
of care challenging.4
Individuals’ perspectives about their health 
are most useful to care providers when these 
first- hand accounts are both relevant and reli-
ably measured.5 A patient- reported outcome 
(PRO) is ‘a measurement of any aspect of 
a patient’s health that comes directly from 
the patient without the interpretation of the 
patient’s responses by anyone else’.6 PROs 
include symptom severity of the impact of a 
disease or its treatment on a patient’s health- 
related quality of life (including functioning 
and social and emotional well- being).7 PROs 
are typically measured using self- report 
questionnaires known as patient- reported 
outcome measures (PROMs).
PROs are implemented widely across 
different levels of healthcare.8 At an individual 
Strengths and limitations of this study
 ► This scoping review will follow the Preferred 
Reporting Items for Systematic Reviews and Meta- 
analyses (PRISMA) guidelines for the conduct of 
scoping reviews, ensuring transparency and rigour.
 ► Service user and community involvement in the de-
sign and conduct of the review will ensure that the 
findings are supported by stakeholder experiences, 
further helping to identify evidence gaps and re-
search priorities.
 ► An appraisal of the methodological quality of studies 
is not a requirement of a scoping review; however, 
a quality appraisal of the included research articles 
will be conducted to gather insights into the types, 
sources and quality of the evidence around the use 
of patient- reported outcomes in adult social care.
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level, PROs may be used to inform decision- making 
around treatment, monitor disease symptoms and treat-
ment adherence and facilitate communication between 
the patient and their clinical team. At a systems level, 
PROs may be used to support benchmarking including 
service evaluation and commissioning of services, inform 
policymaking and support quality improvement initia-
tives. PROs are used as endpoints within clinical trials, 
support regulatory approval of new medicinal products 
and devices and inform clinical guidelines and health 
policy.5 9 10 PROs are valued due to their capability to 
ensure that the patient’s unique perspective is repre-
sented in the measurement of health and when capturing 
the effectiveness of healthcare interventions.
Despite their established use in healthcare, the role of 
PROs and PROMs in social care is less clear. Published 
reviews have tended to study PROMs within a specific 
context, health condition or population. For example, 
reviews have explored the use of PROMs in primary care 
and investigated stakeholders’ perspectives regarding the 
use of PROMs with frail, older adults living at home.11 12 
Reviews have also been conducted that focus on the use of 
PROMs in end- of- life care and in the care of people with 
dementia and other long- term conditions.13–16 To date, 
a review focussing on the use of PROMs in the broader 
context of adult social care has not been identified.
The Care Act (2014) places a duty on local authorities 
to ensure that the well- being of individuals is placed at the 
heart of care and support.17 Commensurately, in social 
care, PROMs have focused on measuring the wider deter-
minants of well- being (eg, personal dignity, control by an 
individual, participation in work or training and mental, 
physical and emotional health) and social care- related 
quality of life.18 However, it has been suggested that health, 
as a component of well- being, may be more appropriately 
measured with health- related PROMs as a complement 
existing social care measures.19 20 A better understanding 
of how health and social care- related PROMs are used 
in the delivery of care and support, by whom, and the 
barriers and facilitators to their utilisation may be consid-
ered increasingly relevant as decision- making around 
care and support becomes more person focussed and 
data driven.21 A comprehensive understanding of PROs 
may be particularly pertinent as health, care and support 
services move towards greater integration.22 Clarification 
on PROM use is especially timely in light of the COVID-19 
pandemic, which has resulted in the increased use of tele-
medicine, virtual consultations and remote assessment 
and monitoring.23 24 As such, PROMs have the poten-
tial to help people with care and support needs express 
their views about their health (including symptoms, func-
tioning and quality of life) and well- being.25
Consistent with the remit of scoping reviews as a form 
of knowledge synthesis, the aim of this scoping review is to 
explore the existing evidence to understand the current 
state of knowledge on the use of PROs and PROMs in 
adult social care. To achieve this aim, the specific review 
objectives are: (1) to identify PROMs used by people to 
meet their own direct care and support needs, (2) to 
characterise how PROMs have been used in this context; 
and to chart the evidence relating to (3) their effective-
ness, (4) barriers and facilitators to their implementation 
and (5) stakeholder views on their use. A subanalysis to 
explore the use of PROMs in the delivery of integrated 
health and social care will also be undertaken.26
A shared language for PROs
The term ‘patient- reported outcome’ is a reflection of 
PROs’ origins in medicine and healthcare. However, in 
the context of social care people with care and support 
needs rarely identify as patients, preferring to identify 
as service users or citizens.27 In this review on the use of 
PROs within adult social care, the terms ‘person- reported 
outcome’ and ‘person- reported outcome measure’ will be 
used.
METHODS AND ANALYSIS
Protocol design, registration and reporting
Scoping reviews are conducted to understand the existing 
research on a given topic and often serve as a precursor 
to systematic reviews.28 Specifically, scoping reviews seek 
to identify and map the available evidence and, in so 
doing, identify knowledge gaps and directions for future 
research.29 Frequently, scoping reviews are comple-
mented by stakeholder consultation exercises to ensure 
a holistic understanding of the topic that is informed by 
both the published evidence and lived experience.30 This 
scoping review will use the methodology proposed by the 
Joanna Briggs Institute, supported by the original scoping 
framework proposed by Arksey and O’Malley and Peters 
et al.30 31 The Preferred Reporting Items for System-
atic Reviews and Meta- analyses (PRISMA) guidance for 
protocol development and scoping reviews and Joanna 
Briggs Institute (JBI) reporting checklists were consulted 
when preparing this protocol.31–33 This review protocol 




The review will consider sources of evidence that report 
on adults ( ≥  18 years of age) who are direct users of social 
care services or receive integrated health and social care. 
No limitations with regards to an individual’s health 
condition(s) will be applied.
Concept
Sources of evidence that provide information on any 
PROM used in integrated or social care will be consid-
ered for inclusion in the review. Self- report instruments 
that are proxy- reported and carer- reported measures will 
be excluded.
Context
Sources of evidence reporting on a social care or integrated 
care intervention will be considered. An intervention may 
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be defined as an ‘action where someone gets involved 
to improve a situation or prevent it getting worse’ that 
is undertaken with, or on behalf of, a service user to 
promote independence, provide support, prevent harm 
and enable them to live their lives in accordance with 
their own wishes and beliefs.34 35 Integrated care refers 
to coordinated health and social care that is planned and 
organised around the needs and preferences of the indi-
vidual, their carers and family.22 34 The review will exclude 
studies and other evidence sources set in primary and 
secondary care contexts.
Types of sources
This scoping review will consider all sources of published 
evidence on the use of PROs and PROMs in adult social 
care. Sources of evidence will include primary research 
studies, websites, guidelines, government reports and 
policy documents. Expert opinions, editorials and studies 
reporting secondary data analysis (ie, systematic reviews) 
will also be included.
Information sources
The searches will be conducted in three stages: (1) elec-
tronic database searching, (2) grey literature searching 
and (3) hand searching the reference lists and citations of 
included sources to identify further studies for inclusion. 
Electronic database selection will be based on recommen-
dations for optimal database searching for sensitivity.36
The electronic databases Medline (Ovid), Embase 
(Ovid), PsychInfo (Ovid), HMIC (Ovid), Social Care 
Online (SCIE), ASSIA (Pro Quest) and Web of Science 
(Pro Quest) were searched on 29 September 2020 for the 
period 2010 to present date, with no language limitation. 
Sources published in languages other than English will be 
translated. Grey literature databases, Google and websites 
of government and third sector organisations will be 
searched to locate relevant sources. Hand searching of all 
of the included sources’ reference lists will also be under-
taken. Grey literature will be defined as ‘work that is 
produced on all levels of government, academia, business 
and industry in print and electronic formats but which is 
not controlled by commercial publishers.37 A 10- year date 
limit on searches was considered appropriate for locating 
relevant sources, reflecting the increased use of PROMs 
over the last decade, the introduction of the UK National 
PROMs programme, publication of the FDA’s guidance 
on PROMs and the UK government’s National Health 
Service (NHS) white paper outlining government’s vision 
for greater integration of health and social care.6 38 39
Search strategy
The Medline search strategy will be developed and then 
adapted for use with other databases. The search strategy 
will combine MeSH terms (and relevant synonyms) and 
the Boolean operators “AND” and “OR” for search strings. 
Four concept clusters will be included: (1) the concept 
of interest (ie, PROs and PROMs), (2) the population 
of adults who use social care or integrated care services 
(3) contextual factors including type of integrated care/
social care intervention and (4) PROM implementation 
(eg, barriers and facilitators). Terms were developed by 
the review team with support from an information science 
specialist. Service user partner and coinvestigator (PC) 
was consulted to identify specific search terms related to 
integrated care and social care. The grey literature search 
will take place after searches of the electronic databases 
have been completed to enable to study team to immerse 
themselves in the literature and come to better under-
stand the evidence base. Hand searching of citations and 
reference lists of included documents will be undertaken 
at each stage of the search process. The Medline search 
strategy is presented in online supplemental file 1.
Selection of sources of evidence
A team of reviewers (SEH, GT, CM, SCR) will conduct 
title/abstract and full- text screening of all records against 
prespecified eligibility criteria to ascertain suitability for 
inclusion in the review. All records will be screened inde-
pendently by a minimum of two reviewers. Disagreements 
between reviewers will be resolved through discussion. If 
necessary, a third reviewer will be involved if consensus 
cannot be reached. The eligibility criteria will be pretested 
on a sample of abstracts to ensure that evidence sources 
discussing the use of PROs and PROMs in integrated/
social care are captured. Records identified from elec-
tronic databases, the grey literature and hand searching 
will be imported to Endnote V.9.3.3 ( www. endnote. com) 
reference management software, and duplicate records 
will be removed. All screening will be conducted within 
Endnote. Any retrieved documents deemed to meet the 
inclusion criteria will go forward for full- text review. For 
articles excluded during full- text screening, a reason for 
exclusion will be documented. Disagreements on article 
inclusion will be resolved through discussion by members 
of the review team until consensus is achieved. The study 
selection process will be documented in a PRISMA flow 
diagram.
Critical appraisal of individual sources of evidence
Assessment of the methodological quality of included 
studies is not a requirement of scoping reviews.31 The deci-
sion to undertake a quality appraisal will be governed by 
the number and type of sources identified by the searches. 
If feasible, a formal quality assessment will be undertaken 
using the Critical Appraisal Skills Programme checklists 
and the AACODS (Authority, Accuracy, Coverage, Objec-
tivity, Date, Significance) checklist for quality appraisal 
of the grey literature.40 41 Appraisals will be undertaken 
to characterise the overall quality of the evidence base 
and no study will be excluded on the basis of its meth-
odological quality. Two reviewers will independently 
appraise studies for quality. Findings will be collated by 
study type and presented in tabular format along with a 
textual description of findings. To ensure transparency 
of reporting, interrater agreement and reliability will be 
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determined by calculating an intraclass coefficient (ICC) 
statistic, Cohen’s κ and percentage agreement.42 43
Data charting process
Data extraction, termed data charting in scoping reviews, 
aims to provide a ‘logical and descriptive summary of 
results that align with the review questions’.31 A stan-
dardised template will be developed in Excel and piloted 
prior to commencing data charting. Two reviewers 
will extract key characteristics of the data source and 
information relevant to answering the review questions 
independently. Discrepancies will be resolved through 
discussion. As a scoping review is an iterative process, 
the data extraction form will be refined and updated 
throughout the course of the review and in response to 
the emergent findings.
Data items
The data items to be extracted for each data source 
comprise: (1) the publication title, (2) date of publica-
tion, (3) authors, (4) country (location of study), (5) 
study aims and objectives, (6) study design, (7) study 
setting, (8) whether the intervention is an integrated care 
intervention, (9) study population, (10) study data collec-
tion method, (11) data analysis method. Information 
on community and user involvement, study outcome(s), 
process and system- level outcomes in response to the 
PROM intervention and barriers/enablers to implemen-
tation will also be extracted. PROM- specific information 
will be charted separately and include a list of studies 
using each PROM and, if available, a description of the 
PROMs’ characteristics, including target population, 
construct domains, number of items/subscales, mode of 
administration, recall period, response options, range of 
scores, scoring, language of the original publication and 
available translations.
Data summary
A qualitative content analysis in scoping reviews is gener-
ally descriptive in nature.31 Following data charting, 
findings from the included sources will be collated with 
analysis of common themes relating to the aims of the 
review. Given the anticipated diversity of the included 
data sources, the framework method, using NVivo (V.1.3) 
qualitative data analysis software and Microsoft Excel 
spreadsheets and data charting, will be used to capture key 
themes.44 45 The framework method sits within the family 
of methods described as thematic analysis or content 
analysis. Its hallmark is the systematic construction of a 
matrix that facilitates comparison across and within cases 
(ie, data sources) to produce a thematic interpretation 
of the data. The framework method follows a structured 
format, whereby the reviewers will first become familiar 
with the data source. The data will be reviewed line- by- 
line and coded by applying a paraphrase or label. Coding 
will include a number of a priori deductive codes selected 
for their relevance to the aims of this scoping review to 
chart the evidence of PROM use in adult social care. The 
reviewer will also deploy inductive coding by remaining 
open to the coding of new and unexpected concepts that 
may be emergent in the data. The first few data sources 
will be coded independently by two reviewers. Through 
consensus discussions, the reviewers will agree on a set 
of codes to be applied to all subsequent sources. Codes 
will be grouped into categories to create an analytical 
framework that will be used for indexing the remaining 
data sources. Finally, the coded data will be charted into 
a matrix using a spreadsheet. The characteristics of and 
differences between the data will be identified and a 
description of relationships between categories will be 
developed. Results will be presented using tables and 
diagrams accompanied by a narrative summary.31
Piloting/calibration exercise
All phases of the scoping review will be pretested. The JBI 
recommended procedure for pilot testing will be used.31 
For screening, the titles and abstracts of 25 randomly 
selected articles will be screened by the review team, 
applying the a priori review eligibility criteria. Screening 
will commence once inter- rater agreement of 75% or 
greater is achieved. Inter- rater agreement that is less than 
75% will prompt the study team to review and refine 
the inclusion criteria. This process of pilot testing will 
continue iteratively until the 75% agreement threshold 
is met.
The data charting template will be piloted by two 
reviewers to ensure the capture of data relevant to the 
aims and objective of the review. As the review progresses, 
the reviewers may wish to extract additional information 
of relevance to the review objectives; therefore, further 
revisions to the data chart template may be made itera-
tively as the review progresses.31
Changes to the protocol
The exploratory nature and breadth of a scoping review 
mean that changes to the protocol may be required as 
new information becomes available and as the review 
progresses. Any protocol deviations or refinements, 
together with a rationale for these changes, will be docu-
mented clearly in the review report.
Service user and public involvement
This scoping review was conceived and developed with 
community and user involvement. As coinvestigator 
and a person with lived experience, PC contributed 
to the development of the search strategies, the study 
protocol, consensus discussions and will review all study- 
related documents. A lay summary to facilitate dissemi-
nation of the review findings will be coproduced. In 
addition, this work will be discussed with the NIHR ARC 
West Midlands Long Term Conditions Theme 1 Patient 
and Public Involvement and Engagement Stakeholder 
Advisory Group. Meetings will be held on a quarterly 
basis throughout the review process. The Guidance for 
Reporting Involvement of Patients and the Public-2 short 
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form checklist will be used to document service user and 
public involvement.46
Ethics and dissemination
Ethical approval is not required as this review is a retro-
spective review of publicly available evidence sources. The 
review findings will be disseminated via publication in a 
peer- reviewed journal, symposia and conference presen-
tations. A dissemination strategy to ensure the review 
findings reach relevant stakeholders will be coproduced 
in partnership with members of the review team who are 
experts by experience.
DISCUSSION
PROs can provide key data that enable health and social 
care practitioners to understand better a person’s views 
about their health and well- being, allowing them to 
provide effective, efficient and compassionate care. This 
scoping review will be the first to provide an overview of 
the evidence around the use of PROs with adults who 
use social care services. Given the disparate nature of 
the evidence, the use of a scoping review methodology is 
appropriate as it enables the review to evolve in an itera-
tive manner that is responsive to the evidence.
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